VentriPoint Diagnostics Ltd.
VPTDF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | -1,187% | – | -1,851% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | -1,345.7% | – | -1,939.4% |
| EPS | -0.008 | -0.006 | -0.007 | -0.008 |
| % Growth | -33.9% | 10.6% | 17.5% | – |
| EPS Diluted | -0.008 | -0.006 | -0.007 | -0.008 |
| Weighted Avg Shares Out | 164 | 163 | 157 | 157 |
| Weighted Avg Shares Out Dil | 164 | 163 | 157 | 157 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | -1,170.5% | – | -1,826.9% |